Abstract

Could Hormone Remission be Achieved in Prolactinomas with Surgery?

Highlights

  • Dopamine agonists (DA) are recognized as an effective medical treatmentsince the beginning 1970s[1,2]Normoprolactinemia was achievedin 59%when using bromocriptine[3].Normal PRL level can be achieved in 80-90%when using DA

  • Relevant systemic side effects, including vomiting, nausea, dizziness, headache have been reported in about one third of patients treated with DAs[ 4, 5]

  • DAs have a significant effect on other dopamine, serotonin androgenic receptors, which leads to severe neurological disorders such as postural hypotension or dyskinesia, psychosis, or mania, which provoke compulsive states[ 6,7]

Read more

Summary

Introduction

Dopamine agonists (DA) are recognized as an effective medical treatmentsince the beginning 1970s[1,2]Normoprolactinemia was achievedin 59%when using bromocriptine[3].Normal PRL level can be achieved in 80-90%when using DA. Relevant systemic side effects, including vomiting, nausea, dizziness, headache have been reported in about one third of patients treated with DAs[ 4, 5]. DAs have a significant effect on other dopamine, serotonin androgenic receptors, which leads to severe neurological disorders such as postural hypotension or dyskinesia, psychosis, or mania, which provoke compulsive states[ 6,7]. In some cases these possible complications assume surgery over prolactinomas

Methods
Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.